{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:13Z","timestamp":1792788193752,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0411"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0411"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Research Project of Chongqing Municipal Education Commission","award":["KJQN202300125"],"award-info":[{"award-number":["KJQN202300125"]}],"id":[{"id":"https:\/\/ror.org\/031nm5713","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Chongqing Innovative Medical Device Application Demonstration Project","award":["CQEIC2024MDAD-010"],"award-info":[{"award-number":["CQEIC2024MDAD-010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05131-0","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:46:32Z","timestamp":1782481592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone reduces osteogenic potential through suppressing retinoic acid signaling via NF-\u03baB\/CYP26B1 axis in mesenchymal stem cells"],"prefix":"10.1186","volume":"17","author":[{"given":"Ai-Hua","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yue","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Cheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ge","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"5131_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jot.2020.10.011","volume":"27","author":"C Huang","year":"2021","unstructured":"Huang C, Zheng Y, Bai J, et al. Hepatocyte growth factor overexpression promotes osteoclastogenesis and exacerbates bone loss in CIA mice. Journal of Orthopaedic Translation. 2021;27:9\u201316.","journal-title":"Journal of Orthopaedic Translation"},{"key":"5131_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jot.2022.01.002","volume":"33","author":"W Zhang","year":"2022","unstructured":"Zhang W, Wang N, Yang M, et al. Periosteum and development of the tissue-engineered periosteum for guided bone regeneration. Journal of Orthopaedic Translation. 2022;33:41\u201354.","journal-title":"Journal of Orthopaedic Translation"},{"issue":"1","key":"5131_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11914-019-00498-x","volume":"17","author":"NE Lane","year":"2019","unstructured":"Lane NE. Glucocorticoid-induced osteoporosis: new insights into the pathophysiology and treatments. Curr Osteoporos Rep. 2019;17(1):1\u20137.","journal-title":"Curr Osteoporos Rep"},{"key":"5131_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.908727","volume":"13","author":"MR Laurent","year":"2022","unstructured":"Laurent MR, Goemaere S, Verroken C, et al. Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian Bone Club. Front Endocrinol (Lausanne). 2022;13:908727.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"5131_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00198-019-04906-x","volume":"30","author":"G Adami","year":"2019","unstructured":"Adami G, Saag KG. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int. 2019;30(6):1145\u201356.","journal-title":"Osteoporos Int"},{"issue":"4","key":"5131_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40520-021-01823-0","volume":"33","author":"OD Messina","year":"2021","unstructured":"Messina OD, Vidal LF, Wilman MV, et al. Management of glucocorticoid-induced osteoporosis. Aging Clin Exp Res. 2021;33(4):793\u2013804.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"5131_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1152\/physrev.00011.2015","volume":"96","author":"K Hartmann","year":"2016","unstructured":"Hartmann K, Koenen M, Schauer S, et al. Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev. 2016;96(2):409\u201347.","journal-title":"Physiol Rev"},{"issue":"5","key":"5131_CR8","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1210\/en.2004-1050","volume":"146","author":"FS Wang","year":"2005","unstructured":"Wang FS, Lin CL, Chen YJ, et al. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology. 2005;146(5):2415\u201323.","journal-title":"Endocrinology"},{"issue":"1","key":"5131_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1677\/joe.1.05962","volume":"185","author":"MF Iu","year":"2005","unstructured":"Iu MF, Kaji H, Sowa H, et al. Dexamethasone suppresses Smad3 pathway in osteoblastic cells. J Endocrinol. 2005;185(1):131\u20138.","journal-title":"J Endocrinol"},{"issue":"6","key":"5131_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","volume":"11","author":"A Rauch","year":"2010","unstructured":"Rauch A, Seitz S, Baschant U, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 2010;11(6):517\u201331.","journal-title":"Cell Metab"},{"issue":"2","key":"5131_CR11","first-page":"800","volume":"41","author":"Y Han","year":"2018","unstructured":"Han Y, Zhang L, Xing Y, et al. Autophagy relieves the function inhibition and apoptosis\u2011promoting effects on osteoblast induced by glucocorticoid. Int J Mol Med. 2018;41(2):800\u20138.","journal-title":"Int J Mol Med"},{"key":"5131_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.835720","volume":"13","author":"M Gado","year":"2022","unstructured":"Gado M, Baschant U, Hofbauer LC, et al. Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes. Front Endocrinol (Lausanne). 2022;13:835720.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5131_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"RS Weinstein","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102(2):274\u201382.","journal-title":"J Clin Invest"},{"issue":"8","key":"5131_CR14","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1172\/JCI28084","volume":"116","author":"HJ KIM","year":"2006","unstructured":"KIM HJ, ZHAO H, KITAURA H, et al. Glucocorticoids suppress bone formation via the osteoclast [J]. J Clin Invest. 2006;116(8):2152\u201360.","journal-title":"J Clin Invest"},{"issue":"12","key":"5131_CR15","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1210\/en.2006-0459","volume":"147","author":"D JIA","year":"2006","unstructured":"JIA D, O\u2019BRIEN C A, STEWART S A, et al. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density [J]. Endocrinology. 2006;147(12):5592\u20139.","journal-title":"Endocrinology"},{"key":"5131_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1196\/annals.1402.057","volume":"1116","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Zhao H, Kitaura H, et al. Glucocorticoids and the osteoclast. Ann N Y Acad Sci. 2007;1116:335\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"5131_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13287-021-02347-0","volume":"12","author":"R JIANG H T, DENG","year":"2021","unstructured":"JIANG H T, DENG R, DENG Y, et al. The role of Serpina3n in the reversal effect of ATRA on dexamethasone-inhibited osteogenic differentiation in mesenchymal stem cells [J]. Stem Cell Res Ther. 2021;12(1):291.","journal-title":"Stem Cell Res Ther"},{"key":"5131_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jdb8010006","author":"C Roberts","year":"2020","unstructured":"Roberts C. Regulating Retinoic Acid Availability during Development and Regeneration: The Role of the CYP26 Enzymes. J Dev Biol. 2020. https:\/\/doi.org\/10.3390\/jdb8010006.","journal-title":"J Dev Biol"},{"key":"5131_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bonr.2018.06.006","volume":"9","author":"T LIND","year":"2018","unstructured":"LIND T, LUGANO R, GUSTAFSON A M, et al. Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy Vegfa overexpression [J]. Bone Rep. 2018;9:27\u201336.","journal-title":"Bone Rep"},{"issue":"22","key":"5131_CR20","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1242\/dev.024034","volume":"135","author":"J SPOORENDONK K M, PETERSON-MADURO J,","year":"2008","unstructured":"SPOORENDONK K M, PETERSON-MADURO J, RENN J, et al. Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton [J]. Development. 2008;135(22):3765\u201374.","journal-title":"Development"},{"issue":"5","key":"5131_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s13770-023-00526-z","volume":"20","author":"J YAO X T, LI P P, LIU","year":"2023","unstructured":"YAO X T, LI P P, LIU J, et al. Wnt\/\u03b2-Catenin Promotes the Osteoblastic Potential of BMP9 Through Down-Regulating Cyp26b1 in Mesenchymal Stem Cells [J]. Tissue Eng Regen Med. 2023;20(5):705\u201323.","journal-title":"Tissue Eng Regen Med"},{"issue":"1","key":"5131_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/cr.2010.159","volume":"21","author":"DV NOVACK","year":"2011","unstructured":"NOVACK DV. Role of NF-\u03baB in the skeleton [J]. Cell Res. 2011;21(1):169\u201382.","journal-title":"Cell Res"},{"key":"5131_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.2009.05315.x","volume":"1192","author":"Z BOYCE B F, YAO","year":"2010","unstructured":"BOYCE B F, YAO Z. Functions of nuclear factor kappaB in bone [J]. Ann N Y Acad Sci. 2010;1192:367\u201375.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"5131_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wsbm.1331","volume":"8","author":"S MITCHELL","year":"2016","unstructured":"MITCHELL S, VARGAS J. Signaling via the NF\u03baB system [J]. Wiley Interdiscip Rev Syst Biol Med. 2016;8(3):227\u201341.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"10","key":"5131_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrrheum.2010.133","volume":"6","author":"SA KRUM","year":"2010","unstructured":"KRUM SA, CHANG J, MIRANDA-CARBONI G, et al. Novel functions for NF\u03baB: inhibition of bone formation [J]. Nat Rev Rheumatol. 2010;6(10):607\u201311.","journal-title":"Nat Rev Rheumatol"},{"issue":"6937","key":"5131_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u201342.","journal-title":"Nature"},{"issue":"1","key":"5131_CR27","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1038\/s41598-017-03187-w","volume":"7","author":"SY Lu","year":"2017","unstructured":"Lu SY, Wang CY, Jin Y, et al. The osteogenesis-promoting effects of alpha-lipoic acid against glucocorticoid-induced osteoporosis through the NOX4, NF-kappaB, JNK and PI3K\/AKT pathways. Sci Rep. 2017;7(1):3331.","journal-title":"Sci Rep"},{"issue":"1","key":"5131_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00223-025-01358-w","volume":"116","author":"Y Liu","year":"2025","unstructured":"Liu Y, Deng X, Chen C, et al. Atractylenolide I attenuates glucocorticoid-induced osteoporosis via inhibiting NF-\u03baB signaling pathway. Calcif Tissue Int. 2025;116(1):51.","journal-title":"Calcif Tissue Int"},{"issue":"1\u20134","key":"5131_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bbrc.2018.11.040","volume":"507","author":"X Liang","year":"2018","unstructured":"Liang X, Li B, Huang Q, et al. Klotho prevents DEX-induced apoptosis in MC3T3-E1 osteoblasts through the NF-\u03baB signaling pathway. Biochem Biophys Res Commun. 2018;507(1\u20134):355\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"5131_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/OARRR.S282606","volume":"13","author":"HERMAND KOBZA A O","year":"2021","unstructured":"KOBZA A O HERMAND. Understanding and Managing Corticosteroid-Induced Osteoporosis [J]. Open Access Rheumatol. 2021;13:177\u201390.","journal-title":"Open Access Rheumatol"},{"issue":"12","key":"5131_CR31","first-page":"e5195","volume":"106","author":"J WARD L M, MA","year":"2021","unstructured":"WARD L M, MA J, ROBINSON M E, et al. Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders [J]. J Clin Endocrinol Metab. 2021;106(12):e5195\u2013207.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5131_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00198-017-4241-7","volume":"29","author":"ZE Belaya","year":"2018","unstructured":"Belaya ZE, Grebennikova TA, Melnichenko GA, et al. Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans. Osteoporos Int. 2018;29(1):211\u201321.","journal-title":"Osteoporos Int"},{"issue":"1","key":"5131_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11914-022-00772-5","volume":"21","author":"H Bensreti","year":"2023","unstructured":"Bensreti H, Alhamad DW, Gonzalez AM, et al. Update on the role of glucocorticoid signaling in osteoblasts and bone marrow adipocytes during aging. Current Osteoporosis Reports. 2023;21(1):32\u201344.","journal-title":"Current Osteoporosis Reports"},{"issue":"22","key":"5131_CR34","doi-asserted-by":"publisher","first-page":"e42668","DOI":"10.1097\/MD.0000000000042668","volume":"104","author":"X SONG","year":"2025","unstructured":"SONG X, ZHANG Y, YANG H, et al. Advances in the study and treatment of glucocorticoid osteoporosis: A review [J]. Med (Baltim). 2025;104(22):e42668.","journal-title":"Med (Baltim)"},{"issue":"10","key":"5131_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf146","volume":"9","author":"K Warmink","year":"2025","unstructured":"Warmink K, Lijnzaad P, Schubert SA, et al. Mechanisms of dexamethasone-induced bone toxicity in developing bone: a single-cell perspective. JBMR Plus. 2025;9(10):ziaf146.","journal-title":"JBMR Plus"},{"issue":"5","key":"5131_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00109-017-1512-x","volume":"95","author":"FS Wang","year":"2017","unstructured":"Wang FS, Lian WS, Lee MS, et al. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways. J Mol Med (Berl). 2017;95(5):499\u2013512.","journal-title":"J Mol Med (Berl)"},{"key":"5131_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111267","volume":"529","author":"D Fraher","year":"2021","unstructured":"Fraher D, Mann RJ, Dubuisson MJ, et al. The endocannabinoid system and retinoic acid signaling combine to influence bone growth. Mol Cell Endocrinol. 2021;529:111267.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"5131_CR38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1210\/er.2012-1071","volume":"34","author":"HH Conaway","year":"2013","unstructured":"Conaway HH, Henning P, Lerner UH. Vitamin a metabolism, action, and role in skeletal homeostasis. Endocr Rev. 2013;34(6):766\u201397.","journal-title":"Endocr Rev"},{"key":"5131_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109279","volume":"118","author":"H Wang","year":"2019","unstructured":"Wang H, Hu Y, He F, et al. All-trans retinoic acid and COX-2 cross-talk to regulate BMP9-induced osteogenic differentiation via Wnt\/\u03b2-catenin in mesenchymal stem cells. Biomed Pharmacother. 2019;118:109279.","journal-title":"Biomed Pharmacother"},{"key":"5131_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biocel.2013.11.018","volume":"47","author":"Y Liu","year":"2014","unstructured":"Liu Y, Liu Y, Zhang R, et al. All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP\/Smad and Wnt\/\u03b2-catenin signaling pathways. Int J Biochem Cell Biol. 2014;47:47\u201356.","journal-title":"Int J Biochem Cell Biol"},{"key":"5131_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.mce.2015.12.018","volume":"422","author":"S Zhang","year":"2016","unstructured":"Zhang S, Chen X, Hu Y, et al. All-trans retinoic acid modulates Wnt3A-induced osteogenic differentiation of mesenchymal stem cells via activating the PI3K\/AKT\/GSK3\u03b2 signalling pathway. Mol Cell Endocrinol. 2016;422:243\u201353.","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"5131_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425250903032681","volume":"5","author":"JE Thatcher","year":"2009","unstructured":"Thatcher JE, Isoherranen N. The role of CYP26 enzymes in retinoic acid clearance. Expert Opin Drug Metab Toxicol. 2009;5(8):875\u201386.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"5131_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev-nutr-072610-145127","volume":"31","author":"AC Ross","year":"2011","unstructured":"Ross AC, Zolfaghari R. Cytochrome P450s in the regulation of cellular retinoic acid metabolism. Annu Rev Nutr. 2011;31:65\u201387.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"5131_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1534-5807(04)00062-0","volume":"6","author":"K Yashiro","year":"2004","unstructured":"Yashiro K, Zhao X, Uehara M, et al. Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb. Dev Cell. 2004;6(3):411\u201322.","journal-title":"Dev Cell"},{"issue":"1","key":"5131_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/sj.cdd.4402047","volume":"14","author":"M Lamkanfi","year":"2007","unstructured":"Lamkanfi M, Festjens N, Declercq W, et al. Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 2007;14(1):44\u201355.","journal-title":"Cell Death Differ"},{"issue":"3","key":"5131_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2019.05.019","volume":"25","author":"M Yamashita","year":"2019","unstructured":"Yamashita M, PASSEGU\u00e9 E. TNF-\u03b1 Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration. Cell Stem Cell. 2019;25(3):357-72.e7.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"5131_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13291","volume":"55","author":"Y Li","year":"2022","unstructured":"Li Y, Zhuang Q, Tao L, et al. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK\/NF-\u03baB pathway. Cell Prolif. 2022;55(10):e13291.","journal-title":"Cell Prolif"},{"issue":"1","key":"5131_CR48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12964-024-01533-w","volume":"22","author":"F Liu","year":"2024","unstructured":"Liu F, Zhao Y, Pei Y, et al. Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance. Cell Communication and Signaling. 2024;22(1):159.","journal-title":"Cell Communication and Signaling"},{"issue":"1","key":"5131_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13075-017-1296-y","volume":"19","author":"T SAITO","year":"2017","unstructured":"SAITO T, TANAKA S. Molecular mechanisms underlying osteoarthritis development: Notch and NF-\u03baB [J]. Arthritis Res Ther. 2017;19(1):94.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5131_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41392-023-01330-w","volume":"8","author":"Q Yao","year":"2023","unstructured":"Yao Q, Wu X, Tao C, et al. Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduction and Targeted Therapy. 2023;8(1):56.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"12","key":"5131_CR51","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.2174\/1568026611313120004","volume":"13","author":"CH Nelson","year":"2013","unstructured":"Nelson CH, Buttrick BR, Isoherranen N. Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics. Curr Top Med Chem. 2013;13(12):1402\u201328.","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"5131_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1389557023406223","volume":"2","author":"VC Njar","year":"2002","unstructured":"Njar VC. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy. Mini Rev Med Chem. 2002;2(3):261\u20139.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"5131_CR53","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0022-3565(24)39233-X","volume":"293","author":"P Stoppie","year":"2000","unstructured":"Stoppie P, Borgers M, Borghgraef P, et al. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents. J Pharmacol Exp Ther. 2000;293(1):304\u201312.","journal-title":"J Pharmacol Exp Ther"},{"key":"5131_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010377","author":"A Xavier","year":"2021","unstructured":"Xavier A, Toumi H, Lespessailles E. Animal Model for Glucocorticoid Induced Osteoporosis: A Systematic Review from 2011 to 2021. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms23010377.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5131_CR55","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/1440-1681.13548","volume":"48","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhong Z, Chen W, et al. Glucocorticoid-induced dose-related and site-specific bone remodelling, microstructure, and mechanical changes in cancellous and cortical bones. Clin Exp Pharmacol Physiol. 2021;48(10):1421\u20139.","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05131-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:17:58Z","timestamp":1789521478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05131-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5131"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05131-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Chongqing Medical University (CQMU). The approved project title was \u201cGlucocorticoids inhibit osteogenic differentiation of mesenchymal stem cells by upregulating CYP21B1\u201d, with the approval number IACUC-CQMU-2025-0049, granted on February 5, 2025. No additional human subjects or embryonic materials were involved in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"319"}}